Biological Trace Element Research

, Volume 73, Issue 2, pp 139–149 | Cite as

Zinc serum level in human immunodeficiency virus-infected patients in relation to immunological status

  • Nele Wellinghausen
  • Winfried V. Kern
  • Wolfgang Jöchle
  • Peter Kern
Article

Abstract

In human immunodeficiency virus (HIV) infection, serum level of zinc, an important micronutrient for immune function, is frequently diminished. The aim of this study was to determine the zinc status in relation to immunological parameters and disease stage in 79 HIV-1 seropositive patients. The median serum level of zinc was within normal limits (12.5 µmol/L) but in 23% of patients, zinc deficiency was seen. Decreased serum zinc was associated with a low CD4 cell count, high viral load, and increased neopterin and IgA levels. According to current treatment recommendations, the majority of patients received antiretroviral triple therapy. Zinc levels in treated and untreated patients were comparable. Referring to disease stage (CDC classification, 1993), the mean zinc level was highest in stage C and lowest in stage A. In conclusion, even under antiretroviral triple therapy, zinc deficiency is still of great importance in HIV infection, and zinc substitution in zinc deficient individuals should be taken into account to optimize therapeutical success.

Index Entries

Zinc human immunodeficiency virus immunology antiretroviral therapy 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    S. Cunningham-Rundles, R. S. Bockmann, A. Lin, P. V. Giardina, M. W. Hilgartner, D. Caldwell-Brown, et al., Physiological and pharmacological effects of zinc on immune response, Ann. NY Acad. Sci. 587, 113–122 (1980).Google Scholar
  2. 2.
    J. F. Bach, The multi-faceted zinc dependency of the immune system, Immunol. Today 4, 225–227 (1981).CrossRefGoogle Scholar
  3. 3.
    N. Wellinghausen, H. Kirchner, and L. Rink, The immunobiology of zinc, Immunol. Today 18, 519–521 (1997).PubMedCrossRefGoogle Scholar
  4. 4.
    M. Baum, L. Cassetti, P. Bonvehi, G. Shor-Posner, Y. Lu, and H. Sauberlich, Inadequate dietary intake and altered nutrition status in early HIV-1 infection, Nutrition 10, 16–20 (1994).PubMedGoogle Scholar
  5. 5.
    M. K. Baum, G. Shor-Posner, Y. Lu, B. Rosner, H. E. Sauberlich, M. A. Fletcher, et al., Micronutrients and HIV-1 disease progression, AIDS 9, 1051–1056 (1995).PubMedCrossRefGoogle Scholar
  6. 6.
    J. Koch, E. A. Neal, M. J. Schlott, Y. L. Garcia-Shelton, M. F. Chan, K. E. Weaver, et al., Zinc levels and infection in hospitalized patients with AIDS, Nutrition 12, 515–518 (1996).PubMedCrossRefGoogle Scholar
  7. 7.
    R. S. Beach, E. Mantero-Atienza, G. Shor-Posner, J. J. Javier, J. Szapocznik, R. Morgan, et al., Specific nutrient abnormalities in asymptomatic HIV-1 infection, AIDS 6, 701–708 (1992).PubMedCrossRefGoogle Scholar
  8. 8.
    T. Harrer, B. Wolf, W. Näger, W. Schwarz, D. Bergner, and J. R. Kalden, In vitro activation of peripheral mononuclear cells by zinc in HIV-infected patients and healthy controls, Clin. Exp. Immunol. 89, 285–289 (1992).PubMedCrossRefGoogle Scholar
  9. 9.
    C. Allavena, B. Dousset, T. May, F. Dubois, P. Canton, and F. Belleville, Relationship of trace element, immunological markers and HIV1 infection progression, Biol. Trace Element Res. 47, 133–138 (1995).Google Scholar
  10. 10.
    M. K. Baum and G. Shor-Posner, Micronutrient status in relationship to mortality in HIV-1 disease, Nutr. Rev. 56, 135–139 (1998).CrossRefGoogle Scholar
  11. 11.
    M. K. Baum, G. Shor-Posner, S. Lai, G. Zhang, H. Lai, M. A. Fletcher, et al., High risk of hIV-related mortality is associated with selenium deficiency, J. Acquir. Immune Defic. Syndr. 15, 370–374 (1997).Google Scholar
  12. 12.
    M. Egger, B. Hirschel, P. Francioli, P. Sudre, M. Wirz, M. Flepp, et al., Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort study, Br. Med. J. 315, 1194–1199 (1997).Google Scholar
  13. 13.
    C. C. Carpenter, M. A. Fischl, S. M. Hammer, M. S. Hirsch, D. M. Jacobsen, D. A. Katzenstein, et al., Antiretroviral therapy for HIV infection in 1996. Updated recommendations of the International AIDS Society—USA, JAMA 277, 1962–1969 (1997).PubMedCrossRefGoogle Scholar
  14. 14.
    Centers for Disease Control, 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults, MMWR 41, 1–19 (1992).Google Scholar
  15. 15.
    K. W. Beck, P. Schramel, A. Hedl, H. Jager, and W. Kaboth, Serum trace element levels in HIV-infected subjects, Biol. Trace Element Res. 25, 89–96 (1990).CrossRefGoogle Scholar
  16. 16.
    L. Isa, A. Lucchini, S. Lodi, and M. Giachetti, Blood zinc status and zinc treatment in human immunodeficiency virus-infected patients, Int. J. Clin. Lab. Res. 22, 45–47 (1992).PubMedCrossRefGoogle Scholar
  17. 17.
    N. Wellinghausen, W. Jöchle, S. Reuter, W. A. Flegel, A. Grünert, and P. Kern, Zinc status in patients with alveolar echinococcosis is related to disease progression, Parasite Immunol. 21, 237–241 (1999).PubMedCrossRefGoogle Scholar
  18. 18.
    J. M. Zeller, N. L. McCain, and B. Swanson, Immunological and virological markers of HIV disease progression, JANAC 7, 15–27 (1996).PubMedCrossRefGoogle Scholar
  19. 19.
    C. M. Tsoukas and N. F. Bernard, Markers predicting progression of human immunodeficiency virus-related disease, Clin. Microbiol. Rev. 7, 14–28 (1994).PubMedGoogle Scholar
  20. 20.
    B. Melichar, R. Zangerle, E. Artner-Dworzak, H. Wachter, and D. Fuchs, Are disturbances of zinc metabolism in human immunodeficiency virus type 1 (HIV-1) infection caused by immune activation? Pteridines 4, 195–199 (1993).Google Scholar
  21. 21.
    A. D. Frankel and J. A. Young, HIV-1: fifteen proteins and an RNA, Annu. Rev. Biochem. 67, 1–25 (1998).PubMedCrossRefGoogle Scholar
  22. 22.
    J. Kushner, The phenomenon of the acute phase response, Ann. NY Acad. Sci. 389, 39–48 (1982).PubMedCrossRefGoogle Scholar
  23. 23.
    A. Singh, B. L. Smoak, K. Y. Patterson, L. G. LeMay, C. Veillon, and P. A. Deutster, Biochemical indices of selected trace elements and minerals in men: effect of stress, Am. J. Clin. Nutr. 53, 126–131 (1991).PubMedGoogle Scholar
  24. 24.
    E. Mocchegiani, S. Veccia, F. Ancarani, G. Scalise, and N. Fabris, Benefit of oral zinc supplementation as an adjunct to zidovudine (AZT) treatment against opportunistic infection in AIDS, Int. J. Immunopharmacol. 17, 719–727 (1995).PubMedCrossRefGoogle Scholar
  25. 25.
    A. M. Tang, N. M. H. Graham, and A. J. Saah, Effects of micronutrient intake on survival in human immunodeficiency virus type 1 infection, Am. J. Epidemiol. 143, 1244–1256 (1996).PubMedGoogle Scholar
  26. 26.
    R. K. Chandra, Excessive intake of zinc impairs immune responses, J. Am. Med. Assoc. 252, 1443–1446 (1984).CrossRefGoogle Scholar

Copyright information

© Humana Press Inc 2000

Authors and Affiliations

  • Nele Wellinghausen
    • 1
  • Winfried V. Kern
    • 1
  • Wolfgang Jöchle
    • 2
  • Peter Kern
    • 1
  1. 1.Section of Infectious Diseases and Clinical ImmunologyMedical University of UlmUlmGermany
  2. 2.Department of Clinical ChemistryMedical University of UlmUlmGermany

Personalised recommendations